Терапия и профилактика посттравматического стрессового расстройства при чрезвычайных ситуациях (алгоритм биологической терапии) : Алгоритм биологической терапии

Аннотация
Посттравматическое стрессовое расстройство (ПТСР) является тяжелым, как правило хроническим, психическим расстройством, принадлежащим к кругу тревожных расстройств и имеющим серьезные последствия для личностного, семейного, трудового и социального функционирования пациента. ПТСР характеризуется широким набором тревожных, невротических, аффективных и психотических симптомов, которые плохо поддаются терапии. Наиболее эффективно при лечении ПТСР применение комбинированной фармако- и психотерапии. Единственными препаратами, одобренными в международных клинических рекомендациях в качестве первого выбора, являются только три селективных ингибитора обратного захвата серотонина – сертралин, пароксетин и флуоксетин, а также один селективный ингибитор обратного захвата серотонина и норадреналина – венлафаксин. Некоторые атипичные антипсихотики, антиконвульсанты, альфа-адреноблокаторы и бензодиазепины используются в основном для аугментации эффекта антидепрессантов и психотерапии или для симптоматической терапии. Среди экспериментальных методов лечения, нуждающихся в дальнейшем изучении, следует указать на гормональные нейромодуляторы, антагонисты каннабиноидных рецепторов, антагонисты метаботропных глутаматных рецепторов, антагонисты глюкокортикоидных рецепторов, некоторые психостимуляторы и противовоспалительные препараты, а также новые методы нейростимуляции, прежде всего транскраниальную магнитную стимуляцию. Однако, только половина больных достигают ремиссии при проведении такой терапии, поэтому в реальной клинической практике широкое распространение получили симптоматическая терапия, применение препаратов вне показаний и полипрагмазия, связанная с попытками воздействия на разнообразную коморбидную психопатологическую симптоматику. Настоящий нарративный обзор посвящен анализу литературы и имеющимся доказательным исследованиям методов профилактики и терапии ПТСР, на основании которых предложен алгоритм биологической терапии ПТСР.
Ключевые слова
посттравматическое стрессовое расстройство, чрезвычайные ситуации, фармакотерапия, психотерапия, доказательные исследования, алгоритм терапии
Библиографические ссылки
- ICD-11.-6B41. Complex post-traumatic stress disorder. ICD-WHO-INT. – Available at: https://icd.who.int/browse11/l-m/en#/http://id.who.int/icd/entity/585833559%2018.10 (accessed September 19, 2022).
- Brewin C.R., Cloitre M., Hyland P. et al. A review of current evidence regarding the ICD-11 proposals for diagnosing PTSD and complex PTSD // Clin Psychol Rev. – 2017. – Vol. 58. – Pp. 1–15. – DOI: https://doi.org/10.1016/j.cpr.2017.09.001
- Kessler R.C., Kazdin A.E., Aguilar-Gaxiola S. et al. Patterns and correlates of patient-reported helpfulness of treatment for common mental and substance use disorders in the WHO World Mental Health Surveys. // World Psychiatry. – 2022. – Vol. 21, no. 2. – Pp. 272–286. – DOI: https://doi.org/10.1002/wps.20971
- Kessler R.C., Chiu W.T., Demler O. et al. Prevalence, severity, and comorbidity of twelvemonth DSM-IV disorders in the National Comorbidity Survey Replication (NCS-R) // Archives of General Psychiatry. — 2005. – Vol. 62, no. 6. – Pp. 617–627. – DOI: https://doi.org/10.1001/archpsyc.62.6.617
- Stein D.J., Ipser J.C., Seedat S. Pharmacotherapy for posttraumatic stress disorder (PTSD) // Cochrane Database Systematic Reviews. – 2006. – No. 1. – CD002795. – DOI: https://doi.org/10.1002/14651858
- Bisson J., Andrew M. Psychological treatment of post-traumatic stress disorder (PTSD) // Cochrane Database of Systematic Reviews. – 2007. – No. 3. – CD003388. – DOI: https://doi.org/10.1002/14651858.cd003388.pub3
- Kessler R.C., Rose S., Koenen K.C. et al. How well can posttraumatic stress disorder be predicted from pre-trauma risk factors? An exploratory study in the WHO World Mental Health Surveys // World Psychiatry. — 2014. – Vol. 13. – Pp. 265–274. – DOI: https://doi.org/10.1002/wps.20150
- Посттравматическое стрессовое расстройство / под ред. В.А. Солдаткина. – Ростов н/Д: Изд-во РостГМУ, 2015. – 624 с.
- Тимошенко П.С. Посттравматическое стрессовое расстройство: новые вызовы современности // Личность, семья, общество: вопросы педагогики и психологии. – 2015. – № 12 (57). – С. 177–181.
- Yehuda R., Hoge C.E., McFarlane A. et al. Post-traumatic stress disorder. // Nat Rev Dis Prim. – 2015. – Vol. 1. – Art. 15057. – DOI: https://doi.org/10.1038/nrdp.2015.57
- Rytwinski N.K., Scur M.D., Feeny N.C., Youngstrom E.A. The co-occurrence of major depressive disorder among individuals with posttraumatic stress disorder: a meta-analysis // Journal Trauma Stress. – 2013. – Vol. 26, no. 3. – Pp. 299–309. – DOI: https://doi.org/10.1002/jts.21814
- Марченко А.А., Крюков Е.В., Шамрей В.К. и др. Военная психиатрия в ХХI веке (современные проблемы и перспективы развития). – СПб.: OOO «СпецЛит», 2022. – 367 с
- Leanne W., Coman J.T., Stetz P.C. et al. Identifying response and predictive biomarkers for Transcranial magnetic stimulation outcomes: protocol and rationale for a mechanistic study of functional neuroimaging and behavioral biomarkers in veterans with pharmacoresistant depression // BMC Psychiatry. – 2021. – Vol. 21, no. 1. – Pp. 1–17. – DOI: https://doi.org/10.1186/s12888-020-03030-z
- Bremner J.D., Elzinga B., Schmahl C., Vermetten E. Structural and functional plasticity of the human brain in posttraumatic stress disorder // Prog Brain Res. – 2008. – Vol. 167. – Pp. 171–186. – DOI: https://doi.org/10.1016/S0079-6123(07)67012-5
- Danan D., Todder D., Zohar J., Cohen H. Is PTSD-phenotype associated with HPA-axis sensitivity? Feedback inhibition and other modulating factors of glucocorticoid signaling dynamics // Int J Mol. Sci. – 2021. – Vol. 22, no. 6050. – DOI: https://doi.org/10.3390/ ijms22116050
- Sherin J.E., Nemeroff C.B. Post-traumatic stress disorder: the neurobiological impact of psychological trauma // Dialogues Clin Neurosci. – 2011. – Vol. 13, no. 3. – Pp. 263–278. – DOI: https://doi.org/10.31887/DCNS.2011.13.2/jsherin
- Beck A.T., Emery G., Greenberg R.L. Anxiety disorders and phobias: A cognitive perspective. – New York: Basic Books, 2005.
- Nader K., Schafe G.E., Le Doux J.E. Fear memories require protein synthesis in the amygdala for reconsolidation after retrieval // Nature. – 2000. – Vol. 17, no. 406 (6797). – Pp. 722–726. – DOI: https://doi.org/10.1038/35021052
- Gil S., Caspi Y., Ben-Ari I.Z. et al. Does memory of a traumatic event increase the risk for posttraumatic stress disorder in patients with traumatic brain injury? A prospective study // Am J Psychiatry. – 2005. – Vol. 162, no. 5. – Pp. 963–969. – DOI: https://doi.org/10.1176/appi.ajp.162.5.963
- Cohen H., Kaplan Z., Matar M. A. et al. Anisomycin, a protein synthesis inhibitor, disrupts traumatic memory consolidation and attenuates posttraumatic stress response in rats // Biol Psychiatry. – 2006. – Vol. 60. – Pp. 767–776. – DOI: https://doi.org/10.1016/j.biopsych.2006.03.013
- Zohar J. et al. New insights into secondary prevention in post-traumatic stress disorder // Dialogues Clin Neurosci. – 2011. – Vol. 13, no. 3. – Pp. 301–309. – DOI: https://doi.org/10.31887/DCNS.2011.13.2/jzohar
- Коханов В.П., Краснов В.Н. Психиатрия катастроф и чрезвычайных ситуаций (теория и практика). – М.: Практическая медицина, 2008. – 448 с.
- Психиатрия чрезвычайных ситуаций: руководство: в 2 т. / под ред. Т.Б. Дмитриевой. М.: ГЭОТАР-Медиа, 2004.
- Zhou Y.G., Shang Z.L., Zhang F. et al. PTSD: past, present and future implications for China // Chin J Traumatol. – 2021. – Vol. 24. – Pp. 187–208. – DOI: https://doi.org/10.1016/j.cjtee.2021.04.011
- Trauma-informed care in behavioral health services. Rockville (MD): Substance abuse and mental health services administration (US). – 2014. – Available at: https://www.ncbi.nlm.nih.gov/books/NBK207192/ (accessed September 19, 2022)
- Brymer M., Jacobs A., Layne C. et al. Psychological first aid: Field operations guide. – 2nd ed. – July, 2006. – Available at: https://www.tampabayhmpc.org
- Mellman T.A., Bustamante V., David D., Fins A. Hypnotic medication in the aftermath of trauma (letter) // J Clin Psychiatry. – 2002. – Vol. 63. – Pp. 1183–1184. – DOI: https://doi.org/10.4088/jcp.v63n1214hHowlett J., Stein M. Prevention of traum
- a and stressor-related disorders: A review // Neuropsychopharmacol. – 2016. – Vol. 41. – Pp. 357–369. – DOI: https://doi.org/10.1038/npp.2015.261
- Ginzburg K., Solomon Z., Bleich A. Repressive coping style, acute stress disorder, and posttraumatic stress disorder after myocardial infarction // Psychosomatic Medicine. – 2002. – Vol. 64. – Pp. 748–757. – DOI: https://doi.org/10.1097/01.psy.0000021949.04969.2e
- Mayou R.A., Ehlers A., Hobbs M. Psychological debriefing for road traffic accident victims. Three-year follow-up of a randomised controlled trial // Br J Psychiatry. – 2000. – Vol. 176. – Pp. 589–593. – DOI: 10.1192/bjp.176.6.589
- Sijbrandij M., Olff M., Reitsma J., Carlier I., Gersons B. Emotional or educational debriefing after psychological trauma: Randomised controlled trial // British Journal of Psychiatry. – 2006. – Vol. 189, no. 2. – Pp. 150–155. – DOI: https://doi.org/10.1192/bjp.bp.105.021121
- Shalev A.Y., Ankri Y., Israeli-Shalev Y. et al. Prevention of posttraumatic stress disorder by early treatment: Results from the Jerusalem trauma outreach and prevention study // Archives of General Psychiatry. – 2011. – Vol. 69, no. 2. – Pp. 166–176. – DOI: https://doi.org/10.1001/archgenpsychiatry.2011.127
- Shalev A.Y., Ankri Y., Gilad M. et al. Long-term outcome of early interventions to prevent posttraumatic stress disorder // J Clin Psychiatry. – 2016. – Vol. 77, no. 5. – Pp. 580–587. – DOI: https://doi.org/10.4088/JCP.15m09932
- Kliem S, Kroger C. Prevention of chronic PTSD with early cognitive behavioral therapy. A meta-analysis using mixed-effects modeling // Behav Res Ther. – 2013. – Vol. 51, no. 11. – Pp. 753–761. – DOI: https://doi.org/10.1016/j.brat.2013.08.005
- Weber M., Schumacher S., Hannig W. et al. Long-term outcomes of psychological treatment for posttraumatic stress disorder: A systematic review and meta-analysis // Psychological Medicine. – 2021. – Vol. 51, no. 9. – Pp. 1420–1430. – DOI: https://doi.org/10.1017/S003329172100163X
- McFarlane A. Can debriefing work? Critical appraisal of theories of interventions and outcomes, with directions for future research // Raphael B. & Wilson J. (eds.). Psychological Debriefing: Theory, Practice and Evidence. – Cambridge: Cambridge University Press, 2000. – Pp. 327–336. – DOI: https://doi.org/10.1017/CBO9780511570148.025
- Gelpin E., Bonne O., Peri T. et al. Treatment of recent trauma survivors with benzodiazepines: a prospective study // J Clin Psychiatry. – 1996. – Vol. 57. – Pp. 390–394. – PMID: 9746445
- Hoskins M., Pearce J., Bethell A. et al. Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis // Br J Psychiatry. – 2015. – Vol. 206, no. 2. – Pp. 93–100. – DOI: https://doi.org/10.1192/bjp.bp.114.148551
- Guina J., Rossetter S.R., DeRhodes B.J. et al. Benzodiazepines for PTSD: A systematic review and meta-analysis // J Psychiatr Pract. – 2015. – Vol. 21, no. 4. – Pp. 281–303. – DOI: https://doi.org/10.1097/PRA.0000000000000091
- Argolo F.C., Cavalcanti-Ribeiro P., Netto L.R., Quarantini L.C. Prevention of posttraumatic stress disorder with propranolol: A meta-analytic review // J Psychosom Res. – 2015. – Vol. 79, no. 2. – Pp. 89–93. – DOI: https://doi.org/10.1016/j.jpsychores.2015.04.006
- Giustino T.F., Fitzgerald P.J., Maren S. Revisiting propranolol and PTSD: memory erasure or extinction enhancement? // Neurobiol Learn Mem. – 2016. – Vol. 130. – Pp. 26–33. – DOI: https://doi.org/10.1016/j.nlm.2016.01.009
- Kobayashi I., Sledjeski E., Fallon W. et al. Effects of early albuterol (salbutamol) administration on the development of posttraumatic stress symptoms // Psychiatry Res. – 2011. – Vol. 185. – Pp. 296–298. – DOI: https://doi.org/10.1016/j.psychres.2009.10.016
- Stoddard F.J., Luthra R., Sorrentino E.A. et al. A randomized controlled trial of sertraline to prevent posttraumatic stress disorder in burned children // J Child Adolesc Psychopharmacol. – 2011. – Vol. 21, no. 5. – Pp. 469–477. – DOI: https://doi.org/10.1089/cap.2010.0133
- Suliman S., Seedat S., Pingo J. et al. Escitalopram in the prevention of posttraumatic stress disorder: a pilot randomized controlled trial // BMC Psychiatry. – 2015. – Vol. 15. – Pp. 24–30. – DOI: https://doi.org/10.1186/s12888-015-0391-3
- Zohar J., Yahalom H., Kozlovsky N. et al. High dose hydrocortisone immediately after trauma may alter the trajectory of PTSD: interplay between clinical and animal studies // Eur Neuropsychopharmacol. – 2011. – Vol. 21, no. 11. – Pp. 796–809. – DOI: https://doi.org/10.1016/j.euroneuro.2011.06.001
- Delahanty D.L., Gabert-Quillen C., Ostrowski S.A. et al. The efficacy of initial hydrocortisone administration at preventing posttraumatic distress in adult trauma patients: a randomized trial // CNS Spectr. – 2013. – Vol. 18. – Pp. 103–111. – DOI: https://doi.org/10.1017/S1092852913000096
- McGhee L., Maani C., Garza T. et al. The correlation between ketamine and posttraumatic stress disorder in burned service members // J Trauma. – 2008. – Vol. 64, suppl. 2. – Pp. 195–198. – DOI: https://doi.org/10.1097/TA.0b013e318160ba1d
- Feder A., Parides M.K., Murrough J.W. et al. Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial // JAMA Psychiatry. – 2014. – Vol. 71, no. 6. – Pp. 681–688. – DOI: https://doi.org/10.1001/jamapsychiatry.2014.62
- Stein M., Kerridge C., Dimsdale J., Hoyt D. Pharmacotherapy to prevent PTSD: Results from a randomized controlled proof-of-concept trial in physically injured patients // J Trauma Stress. – 2007. – Vol. 20. – Pp. 923–932.
- Van Zuiden M., Frijling J.L., Nawijn L. et al. Intranasal oxytocin to prevent posttraumatic stress disorder symptoms: a randomized controlled trial in emergency department patients // Biol Psychiatry. – 2017. – Vol. 81. – Pp. 1030–1040. – DOI: https://doi.org/10.1016/j. biopsych.2016.11.012
- Amos T., Stein D., Ipser J. Pharmacological interventions for preventing post-traumatic stress disorder (PTSD) // Cochrane Database of Syst Rev. – 2014, no. 7. – CD006239. – DOI: https://doi.org/10.1002/14651858.CD006239.pub2
- Sijbrandij M., Kleiboer A., Bisson J. et al. Pharmacological prevention of post-traumatic stress disorder and acute stress disorder: a systematic review and meta-analysis // The Lancet Psychiatry. – 2015. – Vol. 2, no. 5. – Pp. 413–421. – DOI: https://doi.org/10.1016/S2215-0366(14)00121-7
- Astill Wright L., Sijbrandij M., Sinnerton R. et al. Pharmacological prevention and early treatment of post-traumatic stress disorder and acute stress disorder: a systematic review and meta-analysis // Transl Psychiatry. – 2019. – Vol. 9. – Pp. 334–345. – DOI: https://doi.org/10.1038/s41398-019-0673-5
- Bertolini F., Robertson L., Bisson J.I. et al. Early pharmacological interventions for universal prevention of post-traumatic stress disorder (PTSD). // Cochrane Database of Systematic Reviews. – 2022. – N 2. – Art. No.: CD013443. DOI: 10.1002/14651858.CD013443.pub2
- Bandelow B., Sher L., Hollander E. et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety disorders, obsessive–compulsive disorder and posttraumatic stress disorder in primary care // World J Biol Psychiatry. – 2012. – Vol. 16, no. 4. – Pp. 77–84. – DOI: https://doi.org/10.3109/13651501.2012.667114
- Lee D.J., Schnitzlein C.W., Wolf J.P. et al. Psychotherapy versus pharmacotherapy for posttraumatic stress disorder: systemic review and meta-analyses to determine firstline treatments // Depress Anxiety. – 2016. – Vol. 33, no. 9. – Pp. 792–806. – DOI: https://doi.org/10.1002/da.22511
- VA/DOD Clinical practice guideline for the management of posttraumatic stress disorder and acute stress disorder: Clinician summary. Version 3.0 // Focus. – 2018. – Vol. 16. – Pp. 430–448. – DOI: https://doi.org/10.1176/appi.focus.16408
- Simiola V., Neilson E.C., Thompson R. et al. Preferences for trauma treatment: A systematic review of the empirical literature // Psychol Trauma. – 2015. – Vol. 7, no. 6. – Pp. 516–524. – DOI: https://doi.org/10.1037/tra0000038
- Watts B.V., Schnurr P.P., Mayo L. et al. Meta-analysis of the efficacy of treatments for posttraumatic stress disorder // J Clin Psychiatry. – 2013. – Vol. 74, no. 6. – Pp. 541–550. – DOI: https://doi.org/10.4088/JCP.12r08225
- Williams T., Phillips N.J., Stein D.J., Ipser J.C. et al., Pharmacotherapy for post-traumatic stress disorder (PTSD) // Cochrane Database Syst Rev. – 2022. – Vol. 3. – CD002795. – DOI: https://doi.org/10.1002/14651858.CD002795.pub3
- Davidson J., Baldwin D., Stein D.J. et al. Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial // Arch Gen Psychiatry. – 2006. – Vol. 63, no. 10. – Pp. 1158–1165. – DOI: https://doi.org/10.1001/archpsyc.63.10.1158
- Cipriani A., Williams T., Nikolakopoulou A., et al. Comparative efficacy and acceptability of pharmacological treatments for post-traumatic stress disorder in adults: A network meta-analysis // Psychological Medicine. – 2018. – Vol. 48, no. 12. – Pp. 1975–1984. – DOI: https://doi.org/10.1017/S003329171700349X
- Hoskins V.D., Bridges J., Sinnerton R. et al. Pharmacological therapy for post-traumatic stress disorder: a systematic review and meta-analysis of monotherapy, augmentation and head-to-head approaches // European Journal of Psychotraumatology. – 2021. – Vol. 12. – Pp. 1–12. – DOI: https://doi.org/10.1080/20008198.2020.1802920
- Davidson J., Kudler H., Smith R. et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. // Arch Gen Psychiatry. - 1990. – Vol. 47. – P. 259-66. DOI: 10.1001/archpsyc.1990.01810150059010
- Kosten T.R., Frank J.B., Dan E. et al. Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine. // J Nerv Ment Dis. - 1991. – Vol. 179. – P. 366-370. DOI: 10.1097/00005053-199106000-00011
- Davidson J.R. Remission in post-traumatic stress disorder (PTSD): effects of sertraline as assessed by the Davidson trauma scale, clinical global impressions and the clinician-administered PTSD scale // Int Clin Psychopharmacol. – 2004. – Vol. 19, no. 2. – Pp. 85–87. – DOI: https://doi.org/10.1097/00004850-200403000-00005
- Gasparyan A., Navarroa D., Navarretea F., Manzanares J. Pharmacological strategies for post-traumatic stress disorder (PTSD): From animal to clinical studies // Neuropharmacology. – 2022. – Vol. 218. – n109211. – DOI: https://doi.org/10.1016/j.neuropharm.2022.109211
- Волошин В.М., Мосолов С.Н. Современные подходы к терапии посттравматического стрессового расстройства (на примере применения сертралина) / Новые достижения в терапии психических заболеваний. - М. –БИНОМ, - 2002. - с. 433-444
- Hamner M.B., Hernandez-Tejada M.A., Zuschlag Z.D. et al. Ziprasidone augmentation of SSRI antidepressants in posttraumatic stress disorder: a randomized, placebo-controlled pilot study of augmentation therapy // J Clin Psychopharmacol. – 2019. – Vol. 39, no. 2. – Pp. 153–157. – DOI: https://doi.org/10.1097/JCP.0000000000001000
- Adetunji B., Mathews M., Williams A. et al. Use of antipsychotics in the treatment of posttraumatic stress disorder // Psychiatry (Edgmont). – 2005. – Vol. 2, no. 4. – Pp. 43– 47. – PMID: 21179651
- De Moraes Costa G., Zanatta F.B., Ziegelmannet P.K. et al. Pharmacological treatments for adults with post-traumatic stress disorder: a network meta-analysis of comparative efficacy and acceptability // J. Psychiatr. Res. – 2020. – Vol. 130. – Pp. 412–420. – DOI: 10.1016/j.jpsychires.2020.07.046
- Villarreal G., Hamner M.B., Canive J.M. et al. Efficacy of Quetiapine Monotherapy in Posttraumatic Stress Disorder: A Randomized, Placebo-Controlled Trial. // Am J Psychiatry. - 2016. – Vol. 173. – P. 1205-1212. DOI: 10.1176/appi.ajp.2016.15070967
- Tucker P., Trautman R.P., Wyatt D.B. et al. Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: a randomized, double-blind, placebo-controlled study // J Clin Psychiatr. – 2007. – Vol. 68, no. 2. – Pp. 201–206. – DOI: https://doi.org/10.4088/jcp.v68n0204
- Yeh M.S., Mari J.J., Costa M.C. et al. A double-blind randomized controlled trial to study the efficacy of topiramate in a civilian sample of PTSD // CNS Neurosci Ther. – 2011. – Vol. 17, no. 5. – Pp. 305–310. – DOI: https://doi.org/10.1111/j.1755-5949.2010.00188.x
- Varma A., Moore M.B., Miller C.W.T., Himelhochet S. et al. Topiramate as monotherapy or adjunctive treatment for posttraumatic stress disorder: a meta-analysis // J Trauma Stress. – 2018. – Vol. 31, no. 1. – Pp. 125–133. – DOI: https://doi.org/10.1002/jts.22251
- Lindley S.E., Carlson E.B., Hill K., A randomized, double-blind, placebo-controlled trial of augmentation topiramate for chronic combat-related posttraumatic stress disorder // J Clin Psychopharmacol. – 2007. – Vol. 27, no. 6. – Pp. 677–681. – DOI: https://doi.org/10.1097/jcp.0b013e31815a43ee
- Clark R.D., Cañive J.M., Calais L.A. et al., Divalproex in posttraumatic stress disorder: an open-label clinical trial // J Trauma Stress. – 1999. – Vol. 12, no. 2. – Pp. 395–401. – DOI: https://doi.org/10.1023/A:1024797014210
- Hamner M.B., Faldowski R.A., Robert S. et al. A preliminary controlled trial of divalproex in posttraumatic stress disorder // Ann Clin Psychiatr. – 2009. – Vol. 21, no. 2. – Pp. 89–94. – PMID: 19439158
- Davis L.L., Davidson J.R., Ward L.C. et al., Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population // J Clin Psychopharmacol. – 2008. – Vol. 28, no. 1. – Pp. 84–88. – DOI: https://doi.org/10.1097/JCP.0b013e318160f83b
- Hertzberg M.A., Butterfield M.I., Feldman M.E. et al. A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder. // Biol Psychiatry. - 1999. – Vol. 45. – P.1226-1229. DOI: 10.1016/s0006-3223(99)00011-6
- Davidson J.R., Brady K., Mellman T.A. et al. The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder // J Clin Psychopharmacol. – 2007. – Vol. 27, no. 1. – Pp. 85–88. – DOI: https://doi.org/10.1097/JCP.0b013e31802e5115
- Kinrys G., Wygant L., Pardo T.B. et al. Levetiracetam for treatment-refractory posttraumatic stress disorder // J Clin Psychiatr. – 2006. – Vol. 67, no. 2. – Pp. 211–214. – DOI: https://doi.org/10.4088/jcp.v67n0206
- Berlin H.A. Antiepileptic drugs for the treatment of post-traumatic stress disorder // Curr Psychiatr Rep. – 2007. – Vol. 9, no. 4. – Pp. 291–300. – DOI: https://doi.org/10.1007/s11920-007-0035-5
- Baniasadi M., Hosseini G., Fayyazi B. et al. Effect of pregabalin augmentation in treatment of patients with combat-related chronic posttraumatic stress disorder: a randomized controlled trial // J Psychiatr Pract. – 2014. – Vol. 20, no. 6. – Pp. 419–427. – DOI: 10.1097/01.pra.0000456590.12998.41
- Nappi C.M., Drummond S.P., Hall J.M. Treating nightmares and insomnia in posttraumatic stress disorder: a review of current evidence // Neuropharmacology. – 2012. – Vol. 62, no. 2. – Pp. 576–585. – DOI: https://doi.org/10.1016/j.neuropharm.2011.02.029
- Zhang Y., Ren R., Sanford L.D. et al. The effects of prazosin on sleep disturbances in post-traumatic stress disorder: a systematic review and meta-analysis // Sleep Med. – 2020. – Vol. 67. – Pp. 225–231. – DOI: https://doi.org/10.1016/j.sleep.2019.06.010
- Yucel D.E., van Emmerik A.P., Souama C. et al. Comparative efficacy of imagery rehearsal therapy and prazosin in the treatment of trauma-related nightmares in adults: a meta-analysis of randomized controlled trials // Sleep Med Rev. – 2020. – Vol. 50. – N101248. – DOI: https://doi.org/10.1016/j.smrv.2019.101248
- Reist C., Streja E., Tang C.C. et al. Prazosin for treatment of post-traumatic stress disorder: A systematic review and meta-analysis // CNS Spectr. – 2021. – Vol. 26, no. 4. – Pp. 338–344. – DOI: https://doi.org/10.1017/S1092852920001121
- Khazaie H., Nasouri M., Ghadami M.R. Prazosin for trauma nightmares and sleep disturbances in combat veterans with post-traumatic stress disorder // Iran J Psychiatry Behav Sci. – 2016. – Vol. 10, no. 3. – e2603. – DOI: https://doi.org/10.17795/ijpbs-2603
- Raskind M.A., Peterson K., Williams T. et al. A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers re-turned from Iraq and Afghanistan // Am J Psychiatry. – 2013. – Vol. 170. – Pp. 1003–1010. – DOI: https://doi.org/10.1176/appi.ajp.2013.12081133
- Raskind M.A., Peskind E.L., Chow B. et al. Trial of prazosin for post-traumatic stress disorder in military veterans // N Engl J Med. – 2018. – Vol. 378, no. 6. – Pp. 507–517. – DOI: https://doi.org/10.1056/NEJMoa1507598
- Mahabir M., Ashbaugh A.R., Saumier D., Tremblay J. Propranolol’s impact on cognitive performance in post-traumatic stress disorder // J Affect Disord. – 2016. – Vol. 192. – Pp. 98–103. – DOI: https://doi.org/10.1016/j.jad.2015.11.051
- Brunet A., Saumier D., Liu A. et al. Reduction of PTSD symptoms with pre-reactivation propranolol therapy: a randomized controlled trial // Am J Psychiatr. – 2018. – Vol. 175, no. 5. – Pp. 427–433. – DOI: https://doi.org/10.1176/appi.ajp.2017.17050481
- Young C., Butcher R. Propranolol for post-traumatic stress disorder: A review of clinical effectiveness. – Ottawa (ON): Canadian Agency for Drugs and Technologies in Health, 2020 Mar 18. – PMID: 33074615
- Pollack M.H., Hoge E.A., Worthington J.J. et al. Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: a randomized, double-blind, placebocontrolled trial. // J Clin Psychiatry. - 2011. – Vol. 72. – P. 892-897. DOI: 10.4088/JCP.09m05607gry
- Cates M.E., Bishop M.H., Davis L.L. et al. Clonazepam for treatment of sleep disturbances associated with combat-related posttraumatic stress disorder // Ann Pharmacother. – 2004. – Vol. 38, no. 9. – Pp. 1395–1399. DOI: https://doi.org/10.1345/aph.1E043
- Rothbaum B.O., Price M., Jovanovic T. et al. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans // Am J Psychiatr. – 2014. – Vol. 171, no. 6. – Pp. 640–648. – DOI: https://doi.org/10.1176/appi.ajp.2014.13121625
- Lipinska G., Baldwin D.S., Thomas K.G. Pharmacology for sleep disturbance in PTSD // Hum Psychopharmacol. – 2016. – Vol. 31, no. 2. – Pp. 156–163. – DOI: https://doi.org/10.1002/hup.2522
- Kosten T.R., Fontana A., Sernyak M.J., Rosenheck R. Benzodiazepine use in posttraumatic stress disorder among veterans with substance abuse // J Nerv Ment Dis. – 2000. – Vol. 188, no. 7. – Pp. 454–459. – DOI: https://doi.org/10.1097/00005053-200007000-00010
- Schrader C., Ross A. A review of PTSD and current treatment strategies // Mo Med. – 2021. – Vol. 118. – Pp. 546–551. – PMID: 34924624
- Du J., Diao H., Zhou X. et al. Post-traumatic stress disorder: a psychiatric disorder requiring urgent attention // Medical Review. – 2022. – Vol. 2, no. 3. – Pp. 219–243. – DOI: https://doi.org/10.1515/mr-2022-0012
- Liriano F., Hatten C., Schwartz T.L. Ketamine as treatment for post-traumatic stress disorder: a review // Drugs Context. – 2019. – Vol. 8, no. 212305. – DOI: https://doi.org/10.7573/dic.212305
- Ross C., Jain R., Bonnett C. J., Wolfson P. High-dose ketamine infusion for the treatment of posttraumatic stress disorder in combat veterans // Ann Clin Psychiatr. – 2019. – Vol. 31, no. 4. – Pp. 271–279. – PMID: 31675388
- Feder A., Costi S., Rutter S.B. et al. A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder. // Am J Psychiatry. - 2021. – Vol. 178. - P. 193-202. DOI: 10.1176/appi.ajp.2020.20050596
- Difede J., Cukor J., Wyka K. et al. D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial // Neuropsychopharmacology. – 2014. – Vol. 39, no. 5. – Pp. 1052–1058. – DOI: https://doi.org/10.1038/npp.2013.317
- Baker J.F., Cates M.E., Luthin D.R. D-cycloserine in the treatment of posttraumatic stress disorder. // Mental Health Clinician. – 2017. – Vol. 7, no. 2. – Pp. 88–94. – DOI: https://doi.org/10.9740/mhc.2017.03.088
- Oehen P., Traber R., Widmer V. et al. A randomized, controlled pilot study of MDMA (3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD) // J Psychopharmacol. – 2013. – Vol. 27, no. 1. – Pp. 40–52. – DOI: https://doi.org/10.1177/026988111246
- Mithoefer M.C., Wagner M.T., Mithoefer A.T. et al. Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylene- dioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study // J Psychopharmacol. – 2013. – Vol. 27, no. 1. – Pp. 28–39. – DOI: https://doi.org/10.1177/0269881112456
- Jerome L., Feduccia A.A., Wang J.B. et al. Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: A longitudinal pooled analysis of six phase 2 trials // Psychopharmacology (Berl). – 2020. – Vol. 237, no. 8. – Pp. 2485–2497. – DOI: https://doi.org/10.1007/s00213-020-05548-2
- Elms L., Shannon S., Shannon H., Lewiset N. et al. Cannabidiol in the treatment of posttraumatic stress disorder: a case series // J Alternative Compl Med. – 2019. – Vol. 25. – Vol. 4. – Pp. 392–397. – DOI: https://doi.org/10.1089/acm.2018.0437
- Golier J.A., Caramanica K., Demaria R., Yehuda R. A pilot study of mifepristone in combatrelated PTSD // Depress Res Treat. – 2012. – Vol. 2012, no. 393251. – DOI: https://doi.org/10.1155/2012/393251
- Lago T.R., Brownstein M.J., Page E. et al. The novel vasopressin receptor (V1aR) antagonist SRX246 reduces anxiety in an experimental model in humans: a randomized proof-of-concept study // Psychopharmacology (Berl). – 2021. – Vol. 238, no. 9. – Pp. 2393–2403. – DOI: https://doi.org/10.1007/s00213-021-05861-4
- Flanagan J.C., Hand A., Jarnecke A. et al. Effects of oxytocin on working memory and executive control system connectivity in posttraumatic stress disorder // Exp Clin Psychopharmacol. – 2018. – Vol. 26, no. 4. – Pp. 391–402. – DOI: https://doi.org/10.1037/pha0000197
- Seligowski A.V., Duffy L.A., Julia B., Merker J.B. et al. The renin-angiotensin system in PTSD: a replication and extension // Neuropsychopharmacology. – 2021. – Vol. 46, no. 4. – Pp. 750–755. – DOI: https://doi.org/10.1038/s41386-020-00923-1
- Stein M.B., Jain S., Simon N.M. et al. Randomized, placebo-controlled trial of the angiotensin receptor antagonist losartan for posttraumatic stress disorder // Biol Psychiatr. – 2021. – Vol. 90, no. 7. – Pp. 473–481. – DOI: https://doi.org/10.1016/j.biopsych.2021.05.012
- Kellner C.H., Romanella S.M. ECT as a novel treatment for PTSD // J ECT. – 2019. – Vol. 35, no. 2. – e13. – DOI: https://doi.org/10.1097/YCT.0000000000000535
- Youssef N.A., McCall W.V., Andrade C. The role of ECT in posttraumatic stress disorder: a systematic review // Ann Clin Psychiatr. – 2017. – Vol. 29, no. 1. – Pp. 62–70. – PMID: 28207917
- Saunders N., Downham R., Turman B. et al. Working memory training with tDCS improves behavioral and neurophysiological symptoms in pilot group with post-traumatic stress disorder (PTSD) and with poor working memory // Neurocase. – 2015. – Vol. 21, no. 3. – Pp. 271–278. – DOI: https://doi.org/10.1080/13554794.2014.890727
- Van ‘t Wout M., Longo S.M., Reddy M.K. et al. Transcranial direct current stimulation may modulate extinction memory in posttraumatic stress disorder // Brain Behav. – 2017. – Vol. 7, no. 5. – e00681. – DOI: https://doi.org/10.1002/brb3.681
- van ‘t Wout-Frank M., Shea M.T., Larson V.C. et al. Combined transcranial direct current stimulation with virtual reality exposure for posttraumatic stress disorder: Feasibility and pilot results // Brain Stimul. – 2019. – Vol. 12, no. 1. – Pp. 41–43. – DOI: https://doi.org/10.1016/j.brs.2018.09.011
- Ahmadizadeh M.J., Rezaei M., Fitzgerald P.B. Transcranial direct current stimulation (tDCS) for post-traumatic stress disorder (PTSD): A randomized, double-blinded, controlled trial // Brain Res Bull. – 2019. – Vol. 153. – Pp. 273–278. – DOI: https://doi.org/10.1016/j.brainresbull.2019.09.011
- Reznikov R., Hamani C. Posttraumatic stress disorder: perspectives for the use of deep brain stimulation // Neuromodulation. – 2017. – Vol. 20, no. 1. – Pp. 7–14. – DOI: https://doi.org/10.1111/ner.12551
- Staudt M. D., Telkes I., Pilitsis J.G. Achieving optimal outcomes with deep brain stimulation for posttraumatic stress disorder // J Neurosurg. – 2020. – Vol. 134, no. 6. – Pp. 1711–1713. – DOI: https://doi.org/10.3171/2020.5.JNS201127
- Dobrovolsky A., Bogin V., Meloni E.G. Combining xenon inhalation with trauma memory reactivation to reduce symptoms of posttraumatic stress disorder: Case report, justification of approach, and review of the literature // Prim Care Companion CNS Disord. – 2019. – Vol. 19, no. 21. – 18nr02395. – DOI: https://doi.org/10.4088/PCC.18nr02395
- Langevin J.P., Koek R.J., Schwartz H.N. et al. Neuromodulation for treatment-refractory PTSD // Fed Pract. – 2017. – Vol. 34. – S. 20–33. – PMID: 30766304
- Исполатова Е.Н., Цукарзи Э.Э. Посттравматическое стрессовое расстройство (ПТСР): морфологические субстраты, нейронные сети и перспективы применения транскраниальной магнитной стимуляции (ТМС) // Современная терапия психических расстройств. – 2022. – № 3. – С. 45–49. – DOI: 10.21265/PSYPH.2022.78.73.005
- Harris A., Reece J. Transcranial magnetic stimulation as a treatment for posttraumatic stress disorder: A meta-analysis // Journal of Affective Disorders. – 2021. – Vol. 289. – Pp. 55–65. – DOI: https://doi.org/10.1016/j.jad.2021.04.003
- Погосов А.В., Смирнова Л.В. Посттравматическое стрессовое расстройство // Социальная и клиническая психиатрия. – 2002. – № 3. – С. 42–50.
- Morina N., Wicherts J.M., Lobbrecht J., Priebe S. Remission from post-traumatic stress disorder in adults: a systematic review and meta-analysis of long-term outcome studies // Clin Psychol Rev. – 2014. – Vol. 34, no. 3. – Pp. 249–255. – DOI: https://doi.org/10.1016/j.cpr.2014.03.002
- Cusack K., Jonas D.E., Forneris C.A. et al. Psychological treatments for adults with posttraumatic stress disorder: a systematic review and meta-analysis // Clin Psychol Rev. – 2016. – Vol. 43. – Pp. 128–141. – DOI: https://doi.org/10.1016/j.cpr.2015.10.003
- Hetrick S.E., Purcell R., Garner B., Parslow R. Combined pharmacotherapy and psychological therapies for post-traumatic stress disorder (PTSD) // Cochrane Database Syst Rev. – 2010. – Vol. 7. – CD007316. – DOI: 10.1002/14651858.CD007316.pub2
- American Psychiatric Association (APA). Practice Guideline for the Treatment of Patients with Acute Stress Disorder and Posttraumatic Stress Disorder. – 2004
- American Psychological Association (APA). Clinical Practice Guideline for the Treatment of Posttraumatic Stress Disorder (PTSD) in Adults. – 2017.
- Agency for Healthcare Research and Quality (AHRQ). Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder. – 2018.
- Bisson J.I., Berliner L., Cloitre M. et al. The international society for traumatic stress studies new guidelines for the prevention and treatment of posttraumatic stress disorder: methodology and development process // J Trauma Stress. – 2019. – Vol. 32, no. 4. – Pp. 475–483. – DOI: https://doi.org/10.1002/jts.22421
- National Institute for Clinical Excellence (NICE), Post-Traumatic Stress Disorder (PTSD). NICE Guideline. – 2018. – [NG116]
- Bandelow B., Allgulander C., Baldwin D.S. et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – Version 3. Part II: OCD and PTSD. // The World Journal of Biological Psychiatry. - 2022. - DOI: 10.1080/15622975.2022.2086296
- Martin A., Naunton M., Kosari S. et al. Treatment guidelines for PTSD: a systematic review // J Clin Med. – 2021. – Vol. 10. – Pp. 18–36. – DOI: https://doi.org/10.3390/jcm10184175
- Merz J., Schwarzer G., Gerger H. Comparative efficacy and acceptability of pharmacological, psychotherapeutic, and combination treatments in adults with posttraumatic stress disorder: A network meta-analysis // JAMA Psychiatr. – 2019. – Vol. 76, no. 9. – Pp. 904–913. – DOI: https://doi.org/10.1001/jamapsychiatry.2019.0951
- Bisson J.I., Baker A., Dekker W., Hoskins M. Evidence-based prescribing for post-traumatic stress disorder // Br J Psychiatry. – 2020. – Vol. 216, no. 3. – Pp. 125–126. – DOI: https://doi.org/10.1192/bjp.2020.40
- Coventry P.A., Meader N., Melton H. et al. Psychological and pharmacological interventions for posttraumatic stress disorder and comorbid mental health problems following complex traumatic events: systematic review and component network meta-analysis // PLoS Med. – 2020. – Vol. 17, no. 8. – e1003262.
- Huang Z.D., Zhao Y.-F., Li S. et al. Comparative efficacy and acceptability of pharmaceutical management for adults with post-traumatic stress disorder: a systematic review and meta-analysis // Front Pharmacol. – 2020. – Vol. 11. – Pp. 559–572. – DOI: https://doi.org/10.3389/fphar.2020.00559